PMID: 8962111Dec 10, 1996Paper

Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1

Proceedings of the National Academy of Sciences of the United States of America
X PiaoAlan Bernstein

Abstract

Activating mutations in the Kit receptor tyrosine kinase have been identified in both rodent and human mast cell leukemia. One activating Kit mutation substitutes a valine for aspartic acid at codon 816 (D816V) and is frequently observed in human mastocytosis. Mutation at the equivalent position in the murine c-kit gene, involving a substitution of tyrosine for aspartic acid (D814Y), has been described in the mouse mastocytoma cell line P815. We have investigated the mechanism of oncogenic activation by this mutation. Expression of this mutant Kit receptor tyrosine kinase in a mast cell line led to the selective tyrosine phosphorylation of a 130-kDa protein and the degradation, through the ubiquitin-dependent proteolytic pathway, of a 65-kDa phosphoprotein. The 65-kDa protein was identified as the src homology domain 2 (SH2)-containing protein tyrosine phosphatase SHP-1, a negative regulator of signaling by Kit and other hematopoietic receptors, and the protein product of the murine motheaten locus. This mutation also altered the sites of receptor autophosphorylation and peptide substrate selectivity. Thus, this mutation activates the oncogenic potential of Kit by a novel mechanism involving an alteration in Kit substrate recog...Continue Reading

References

Sep 1, 1992·Neuron·J Schlessinger, A Ullrich
Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S LevY Yarden
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·V DuronioJ W Schrader
Jan 1, 1990·Ciba Foundation Symposium·A BernsteinP Besmer
Jan 1, 1990·Annals of the New York Academy of Sciences·P DubreuilA Bernstein
Jan 1, 1988·Current Topics in Microbiology and Immunology·L D Shultz
Feb 16, 1995·Nature·T Pawson
Mar 12, 1993·Cell·Z SongyangR J Lechleider
Jan 1, 1994·Annual Review of Cell Biology·P van der GeerR A Lindberg
Apr 1, 1995·Journal of the American Academy of Dermatology·J LongleyS Kohn
Oct 7, 1994·Cell·A Ciechanover
Apr 1, 1994·Molecular and Cellular Biology·C E DabrowskiP A Schaffer
Mar 1, 1991·The Journal of Investigative Dermatology·D D Metcalfe

❮ Previous
Next ❯

Citations

Jun 4, 2002·International Journal of Hematology·Peter ValentMichel Arock
May 25, 2005·Experimental Hematology·Alessandro BeghiniLidia Larizza
Feb 11, 2000·The Journal of Allergy and Clinical Immunology·C O Bingham, K F Austen
Dec 3, 1999·The International Journal of Biochemistry & Cell Biology·D Linnekin
Mar 12, 2002·British Journal of Haematology·John T Reilly
May 25, 2002·British Journal of Haematology·Rajeev GuptaBarbara J Bain
Mar 7, 2009·The Journal of Biological Chemistry·Jianmin SunLars Rönnstrand
Nov 24, 1999·The Journal of Experimental Medicine·M Y CaoA Veillette
Mar 4, 2000·The American Journal of Dermatopathology·M J RegueraL Ferrer
Apr 3, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·P J DonovanJ L Resnick
Jan 26, 2002·Molecular and Cellular Biology·Thomas JahnJustus Duyster
Jun 8, 2007·Blood·Thomas JahnKenneth Weinberg
Dec 31, 2004·Stem Cells·Johan LennartssonR Shivakrupa
Jul 2, 2009·Reproduction : the Official Journal of the Society for the Study of Fertility·Sridurga Mithraprabhu, Kate L Loveland
Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·M JeffersG F Vande Woude
Sep 24, 1999·Leukemia & Lymphoma·L K AshmanA C Cambareri
Mar 18, 2000·Leukemia & Lymphoma·L K AshmanA C Cambareri
Mar 8, 2000·Growth Factors·R P Bourette, L R Rohrschneider
Nov 7, 2012·Expert Opinion on Investigational Drugs·Leonie K Ashman, Renate Griffith
Apr 9, 2004·Cancer Investigation·Anette DuensingJonathan A Fletcher
Mar 1, 2005·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Denhí SchnabelHilda Lomelí
Dec 17, 2011·European Journal of Pharmacology·Sebastian DrubeThomas Kamradt
Feb 11, 2010·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Sonia N Bains, Fred H Hsieh
Jan 29, 2000·The Journal of Investigative Dermatology·Y MaB J Longley
Aug 26, 2006·Immunology and Allergy Clinics of North America·Jason Gotlib
Jun 2, 2007·Chemical Biology & Drug Design·Curtis J HenrichKirk R Gustafson
Jun 20, 2006·Best Practice & Research. Clinical Haematology·Ayalew Tefferi, Gary Gilliland
Mar 18, 2006·Experimental Hematology·Shadmehr DemehriMichael W Deininger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.